Bio-Gene Technology (ASX:BGT) EBIT per Share : A$-0.02 (TTM As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Bio-Gene Technology EBIT per Share?

Bio-Gene Technology's EBIT per Share for the six months ended in Jun. 2024 was A$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.02.

During the past 3 years, the average EBIT per Share Growth Rate was 1.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bio-Gene Technology's EBIT per Share or its related term are showing as below:

ASX:BGT' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -1.8 Med: 1.9 Max: 13.7
Current: 1.9

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Bio-Gene Technology was 13.70% per year. The lowest was -1.80% per year. And the median was 1.90% per year.

ASX:BGT's 3-Year EBIT Growth Rate is ranked worse than
51.52% of 1250 companies
in the Biotechnology industry
Industry Median: 2.8 vs ASX:BGT: 1.90

Bio-Gene Technology's EBIT for the six months ended in Jun. 2024 was A$-1.46 Mil.

Bio-Gene Technology EBIT per Share Historical Data

The historical data trend for Bio-Gene Technology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gene Technology EBIT per Share Chart

Bio-Gene Technology Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EBIT per Share

Get a 7-Day Free Trial

-0.02

Bio-Gene Technology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial									-0.01	-0.01	-0.01	-0.01	-0.01

Bio-Gene Technology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bio-Gene Technology's EBIT per Share for the fiscal year that ended in Jun. 2024 is calculated as

	EBIT per Share		(A: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.119	/	185.818
=	-0.02

Bio-Gene Technology's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.459	/	191.967
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02

Bio-Gene Technology (ASX:BGT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bio-Gene Technology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bio-Gene Technology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Gene Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Gene Technology Ltd (ASX:BGT) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000

Website

https://www.bio-gene.com.au

Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance. Its products are Flavocide and Qcide which include a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. The group's product has multiple applications across public health, crop protection, grain storage, and consumer use. It provides new options derived from nature to meet market demand for effective and safe pest management solutions.

Bio-Gene Technology Headlines

From GuruFocus

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

By Business Wire Business Wire • 12-20-2021